Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel dopamine beta-hydroxylase inhibitors identified at BIAL-Portela & Ca.

April 13, 2018

Patient recruitment ongoing in phase I study of BIIB-095

April 13, 2018

University of Ottawa, Lcb Pharma patent nucleoside and nucleotide analogues

April 13, 2018

BMS and Harvard enter fibrosis research collaboration

April 13, 2018

Beijing Tiancheng Pharma divulges new FGFR inhibitors

April 13, 2018

Humanetics obtains NIAID grant to support development of BIO-300 as a medical countermeasure

April 13, 2018

Novel mutation in SMARCE1 gene discovered in OAFNS

April 13, 2018

Adynxx presents promising phase II data from ADYX-004 study of brivoligide

April 13, 2018

RubrYc Therapeutics closes series A financing

April 13, 2018

Phase I trial of TQB-2450 approved and initiated in China

April 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...